Chronic administration of XBD173 ameliorates cognitive deficits and neuropathology via 18 kDa translocator protein (TSPO) in a mouse model of Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Chronic administration of XBD173 ameliorates cognitive deficits and neuropathology via 18 kDa translocator protein (TSPO) in a mouse model of Alzheimer’s disease ; volume:13 ; number:1 ; day:27 ; month:10 ; year:2023 ; pages:1-20 ; date:12.2023
Translational Psychiatry ; 13, Heft 1 (27.10.2023), 1-20, 12.2023
- Creator
-
Pradhan, Arpit Kumar
Neumüller, Tatjana
Klug, Claudia
Fuchs, Severin
Schlegel, Martin
Ballmann, Markus
Tartler, Katharina Johanna
Pianos, Antoine
Garcia, Maria Sanchez
Liere, Philippe
Schumacher, Michael
Kreuzer, Matthias
Rupprecht, Rainer
Rammes, Gerhard
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41398-023-02630-z
- URN
-
urn:nbn:de:101:1-2024011513561845385369
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pradhan, Arpit Kumar
- Neumüller, Tatjana
- Klug, Claudia
- Fuchs, Severin
- Schlegel, Martin
- Ballmann, Markus
- Tartler, Katharina Johanna
- Pianos, Antoine
- Garcia, Maria Sanchez
- Liere, Philippe
- Schumacher, Michael
- Kreuzer, Matthias
- Rupprecht, Rainer
- Rammes, Gerhard
- SpringerLink (Online service)
Other Objects (12)
Activation of translocator protein by XBD173 ameliorates cognitive deficits and neuropathology in an Alzheimer’s mouse model
Nano‐Brake Halts Mitochondrial Dysfunction Cascade to Alleviate Neuropathology and Rescue Alzheimer's Cognitive Deficits
Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer’s disease
Neuropathology of the Alzheimer's continuum: an update
Prophylactic melatonin significantly reduces Alzheimer’s neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPPswe/PS1 mice
In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology
SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation
The microglial translocator protein (TSPO) in Alzheimer’s disease reflects a phagocytic phenotype
NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease
Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer’s disease
Activation of translocator protein by XBD173 ameliorates cognitive deficits and neuropathology in an Alzheimer’s mouse model
Nano‐Brake Halts Mitochondrial Dysfunction Cascade to Alleviate Neuropathology and Rescue Alzheimer's Cognitive Deficits
Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer’s disease
Neuropathology of the Alzheimer's continuum: an update
Prophylactic melatonin significantly reduces Alzheimer’s neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPPswe/PS1 mice
In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology
SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation
The microglial translocator protein (TSPO) in Alzheimer’s disease reflects a phagocytic phenotype
NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease
Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer’s disease
Activation of translocator protein by XBD173 ameliorates cognitive deficits and neuropathology in an Alzheimer’s mouse model
Nano‐Brake Halts Mitochondrial Dysfunction Cascade to Alleviate Neuropathology and Rescue Alzheimer's Cognitive Deficits
Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer’s disease
Neuropathology of the Alzheimer's continuum: an update
Prophylactic melatonin significantly reduces Alzheimer’s neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPPswe/PS1 mice
In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology
SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation
The microglial translocator protein (TSPO) in Alzheimer’s disease reflects a phagocytic phenotype
NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease
Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change